AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 290 filers reported holding AVANOS MED INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $922 | -34.4% | 45,600 | -17.1% | 0.01% | -33.3% |
| Q2 2023 | $1,406 | -0.3% | 55,000 | +16.0% | 0.01% | -10.0% |
| Q1 2023 | $1,410 | -99.6% | 47,400 | +251.7% | 0.01% | +233.3% |
| Q2 2022 | $368,000 | -31.5% | 13,476 | -16.0% | 0.00% | 0.0% |
| Q1 2022 | $537,000 | -35.1% | 16,044 | -33.2% | 0.00% | -25.0% |
| Q4 2021 | $828,000 | +10.5% | 24,007 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $749,000 | +1191.4% | 24,007 | +1418.5% | 0.00% | – |
| Q2 2021 | $58,000 | -15.9% | 1,581 | 0.0% | 0.00% | – |
| Q1 2021 | $69,000 | -5.5% | 1,581 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $73,000 | +37.7% | 1,581 | 0.0% | 0.00% | – |
| Q3 2020 | $53,000 | +15.2% | 1,581 | 0.0% | 0.00% | – |
| Q2 2020 | $46,000 | +7.0% | 1,581 | 0.0% | 0.00% | – |
| Q1 2020 | $43,000 | -18.9% | 1,581 | 0.0% | 0.00% | – |
| Q4 2019 | $53,000 | -10.2% | 1,581 | 0.0% | 0.00% | – |
| Q3 2019 | $59,000 | -14.5% | 1,581 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $69,000 | – | 1,581 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |